Display options
Share it on

Open Forum Infect Dis. 2017 Dec 26;5(1):ofx274. doi: 10.1093/ofid/ofx274. eCollection 2018 Jan.

Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?.

Open forum infectious diseases

Mahsa Abassi, Joshua Rhein, David B Meya, David R Boulware

Affiliations

  1. Infectious Diseases Institute, Kampala, Uganda.
  2. University of Minnesota, Minneapolis, Minnesota.
  3. School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

PMID: 29372172 PMCID: PMC5777480 DOI: 10.1093/ofid/ofx274

Abstract

Treatment of cryptococcosis requires deferred initiation of antiretroviral therapy (ART). Early ART initiation may be detrimental in the context of cryptococcal infection by increasing the risk of immune reconstitution inflammatory syndrome (IRIS). We present 3 cases where early ART initiation in the presence of unrecognized cryptococcal disease had fatal outcomes.

Keywords: HIV; cryptococcal immune reconstitution syndrome; test and treat

References

  1. PLoS One. 2009;4(5):e5575 - PubMed
  2. Clin Infect Dis. 2010 Feb 1;50(3):291-322 - PubMed
  3. Lancet Infect Dis. 2010 Nov;10(11):791-802 - PubMed
  4. N Engl J Med. 2014 Jun 26;370(26):2487-98 - PubMed
  5. N Engl J Med. 1995 Mar 16;332(11):700-5 - PubMed
  6. Curr Opin Infect Dis. 2013 Feb;26(1):26-34 - PubMed
  7. N Engl J Med. 2016 Feb 11;374(6):542-54 - PubMed
  8. Lancet Infect Dis. 2017 Aug;17 (8):873-881 - PubMed
  9. N Engl J Med. 2017 Jul 20;377(3):233-245 - PubMed
  10. Lancet Infect Dis. 2017 Aug;17 (8):790-791 - PubMed
  11. Lancet Infect Dis. 2016 Jul;16(7):809-818 - PubMed

Publication Types

Grant support